Cytokines, as important mediators of immune and inflammatory pathways, communicate the function of distant organs, such as the digestive system and the central nervous system (201)
This stigma is a likely factor in semaglutide use
Our analysis identifies three pivotal ways GLP-1 influences MedTech: segment variability, revenue growth opportunities, and ultimately, a shift toward preventive care
The Action Plan: Week by Week If you've been on Reta for 4-6 weeks with no results, here's a concrete plan: Week 1: Assess and track Take photos and measurements (waist, hips, chest) Log all food intake honestly for 7 days Note subjective effects (appetite, energy, sleep, GI symptoms) Week 2: Adjust dose if needed If no side effects and no satiety changes, titrate up by 0.5-1mg If GI symptoms are present, hold current dose Week 3-4: Optimize protein and training Hit protein target daily (track it) Ensure resistance training 3-4x/week Increase water to 3+ liters Week 5-6: Reassess Compare photos and measurements to week 1 If still no movement, consider diet break or vendor change If body composition is improving (even without scale change), stay the course Frequently Asked Questions Q: Should I increase my dose faster if nothing is happening
A Penn Medicine study found that women taking GLP1 drugs such as Wegovy had a slightly lower rate of breast cancer diagnoses1.6% compared with 2.3% in women not on the drugs but experts stress the difference is less than 1% and not evidence that GLP1 medications prevent cancer
As people age, levels of GSH naturally decrease, leading to chronic disease, decreased mitochondrial health and higher levels of cellular damage and metabolic dysregulation
